TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection
Links shared publicly online about this topic.
- 784total visits
TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection
A new analysis of data from more than 12,000 people with cystic fibrosis (CF) and Pseudomonas aeruginosa (Pa) lung infection in the Cystic Fibrosis Foundation's Patient Registry shows that use of TOBI (Tobramycin Inhalation Solution, USP) was associated with a 21% reduction in mortality in the following year.
View full resource at news-medical.net
Tags: Infection, Lung, Cystic Fibrosis, Mortality
Most Recently Shared on October 22, 2010 at 7:35 am By:
TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection: A new analysis of data from more than ... http://bit.ly/cd3MiF
Advertisement
